PharmaDesign and Euroscreen Form Strategic Alliance for GPCR Deorphanization PharmaDesign, Inc. and Euroscreen s.a. today announced a partnership to identify novel natural peptide ligands for orphan human G protein coupled receptors. PharmaDesign’s proprietary peptide library offers novel opportunities for identification of novel natural ligands while Euroscreen’s expertise in GPCR target discovery, functional screening of orphan receptors and pharmacological characterization will provide rapid screening of PharmaDesign’s Library and subsequent target validation. The partnership will provide novel Targets for partnering with shared income for the companies. - 2006-01-05

Three Disaster Sites to Commence Operation A Belgian company 444.Net N.V. www.444.net engaged in the business of on-line shopping comparison and internet searching service shall open three (3) sites www.tsunami.ws , www.hurricaneforum.info , www.earthquakeonline.info that would cater to disaster circumstances such as server disaster and other disasters, whether natural or man-made, which threatens or have compromised vital data and archival materials. - 2005-12-16 Friend of PRWeb - 15

We Need Moderators Do you want to do something valuable to help the victims of natural disasters without leaving your comfy chair? - 2005-12-16 Friend of PRWeb - 15

The World’s First Forum for Advanced Infection Prevention Provided by Nonwovens EDANA pioneers the first ever conference dedicated to the issue of infection prevention and the solutions that the nonwovens industry can bring. Taking place in Prague on Monday, 20th to Tuesday, 21st March 2006, this global conference, IN CONTROL!, is supported by healthcare institutions, associations and industry. - 2005-12-14

European Patent Awarded for CCR5 Chemokine Receptor, a Crucial Target for Novel AIDS Therapy ICOS extends the Joint patent estate with Euroscreen in Europe - 2005-11-15

Euroscreen Strengthens its Patent Position in the Field of Inflammatory Targets European patent awarded for uses of Chemerin receptor and its natural ligand, both implicated in the control of physiological and pathological inflammatory reactions - 2005-11-09

Euroscreen Awarded US Patent on P2Y13 (GPR86) Receptor Euroscreen SA, today announced the issuance of a US patent which covers the use of a human G-protein-coupled receptor (GPCR) known as the human P2Y13. Euroscreen’s patent protects any screening process using this receptor in order to find compounds that modulate its activity, and thus may have pharmaceutical potential. - 2005-09-20

UN Reform: Democratization Necessary - For a Parliamentary Assembly at the UN At the occassion of the opening of the 60th United Nations General Assembly in New York Members of the European Parliament in Brussels have called for democratizing the UN. - 2005-09-13

Euroscreen Awarded US Patent Covering Mutant Polypeptides of SHIP2, an Emerging Target for the Treatment of Type 2 Diabetes Mellitus Euroscreen SA, today announced the issuance of a US patent which protects specific mutants affected in the catalytic site of the human SHIP2 protein. These are mutant proteins of SH2 domain containing inositolphosphate5-Phosphatase type2 (SHIP2). - 2005-08-31

Bat-Bot Boosts Sonar Research A robotic bat head that can emit and detect ultrasound in the band of frequencies used by the world's bats will give echolocation research a huge boost. - 2005-08-24

NuonSoft releases Wallpaper Cycler 3.1.0.39 NuonSoft has released Wallpaper Cycler 3.1.0.39, an easy to use, yet powerful desktop wallpaper manager to get rid of that boring static wallpaper on your desktop. You can change the wallpaper with a specific delay and/or at specific times. Manage wallpapers in multi-level categories. Make creative layouts for your wallpapers. Add calendars, quotes, notes, rss news headlines, webcams, effects and more to your desktop. Supports more than 20 file formats. - 2005-08-22

Satellite Keeps Railway Safety and Efficiency on Track European researchers have developed an innovative satellite-based control and command system for low-density railway lines that could herald a minor revolution in train transportation management. - 2005-08-21

Microwavable Chips for Wireless Communication A recent EU project designed and developed a new demonstrator microchip that will dramatically cut the cost of producing new wireless products and could mean that a whole range of existing products will be enabled for wireless communication. - 2005-08-19

Alf Interactive Talking Character Has Been Released Alf is an interactive talking character. - 2005-08-17

Euroscreen Receives US Patent Covering Antibodies Which Bind To Delta32 CCR5 Mutant Chemokine Receptor Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key US patent (6,930,174) in the area of CCR5 and diagnostic applications. The patent claims antibodies which specifically bind to the human delta32 mutant of the chemokine receptor CCR5. - 2005-08-16

Cutesolutions, a Belgium-Based Online Training Company, Has Announced the Release of an E-Learning Course on Assertiveness Cutesolutions has announced the release of an innovative e-learning course on assertiveness. The course is based on the use of a set of "Coffee Cards". - 2005-08-14

SuperTrade.com: Knowledge Management for the Masses SuperTrade.com is a new, free Web application that allows users to create lists of bookmarks, comment on those bookmarks, engage in on-line discussions of bookmarked Websites and more. Based on the principles of knowledge management, SuperTrade is much more than a bookmarks site, but less than a blog. - 2005-08-01

CENTR responds to US government principles on Domain Name System management The Council of European National Top Level Domain Registries -- CENTR -- encourages the US Government to look at making root management as automatic, responsive and impartial as possible. - 2005-07-06

ChemDiv and Euroscreen Form Strategic Alliance for GPCR Drug Development ChemDiv, Inc. and Euroscreen s.a. today announced a partnership to discover and develop drug candidates targeting difficult-to-discover drug candidates for high value GPCR family chemokine targets. - 2005-07-01

Video to Keep Traffic Flowing Motorway Traffic Control Centres use a range of sensors for traffic surveillance and control. The shortcomings of one type, magnetic loop detectors, has led researchers to successfully develop algorithms for alternative video sensors. - 2005-06-09

ESPN Classic Sport Dazzles European Viewers With Diamond Prize, in Competition Sponsored by YAM (Young Anterwerp Manufacturers) TV entertainment sports network ESPN Classic Sport has teamed up with diamond co-operative YAM (The Young Antwerp Manufacturers) to hold competition for European viewers. Winner will walk away with diamond valued at €13,000. - 2005-04-22 Friend of PRWeb - 4

More Contrast Rich Movies With the New Beamax High Contrast Fabric Available from April 1st, Beamax introduces the High Contrast screen fabric. The new High Contrast fabric increases the perceived deepness of the black projected on the screen. Additionally, the images are more easily seen in high ambient light conditions (daytime viewing and non-darkened rooms), because the darker parts of the projected images are more visible. The High Contrast fabric is currently available in the M, M-silver, A and A-Velvet screen series. - 2005-04-03 Friend of PRWeb - 7

Euroscreen Awarded US Patent Covering High-Throughput Screening Method Using Aequorin Euroscreen SA, a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a US patent which further protects its useful high-throughput screening platform called AequoScreen™. The claims are related to a widely used diagnostic and screening method of modulators for any GPCR, calcium-coupled channel or any other calcium–coupled protein. - 2005-03-29

Reporting How Research is Contributing to EU Inland Waterway Policy Helping policy makers navigate the latest research on River Information Services (RIS) is a new free brochure that also explains the implications for the future development of Europe’s inland waterways. - 2005-03-25

DataPoint Awarded with Important European Multimedia Award at CeBIT, Germany At the last day of CeBIT the product DataPoint received a 'Golden European Seal of Excellence in Multimedia 2005' for its marketing and product efforts. - 2005-03-20

Taking the Pulse of Europe’s e-Health Market Are Europe’s hospitals equipped to meet e-health opportunities? This type of issue was covered by the Health Information Network Europe (HINE) in the largest ever survey of hospitals in Europe, just one of a range of studies it offers members. - 2005-03-20

Scrap Tire Pyrolysis Residue Upgraded by CBp Europe Patented Technology Shows Cost Reduction Potentials for Replacing or Blending with Carbon Black Samples of raw pyro-carbon residue from EFTI and Kouei Japan scrap tire pyrolysis recycling plants were upgraded using CBp Europe patented and proprietary post-treatment technology. - 2005-02-10 Friend of PRWeb - 65

In Search of Landmines Land-mines kill or maim some 20,000 people every year. Locating these loathsome weapons is vital. But what mine-busters really want is guidance – like that provided by a unique European infrared-camera system – on where to start searching. - 2005-02-10

Euroscreen Announces SHIP2 License with Wyeth Euroscreen s.a. has completed a license agreement with Wyeth for access to the Euroscreen’s SHIP2 patent rights. Financial details of the agreement were not disclosed. - 2005-01-03

Euroscreen Enters Collaboration with Cephalon, Inc. to Discover GPCR-Directed Small Molecule Products Euroscreen s.a. today announced a collaboration with Cephalon, Inc. to discover and develop small molecule therapeutics targeting G-Protein Coupled Receptors, or GPCR, a family of receptors that play a major role in cell signaling. The companies will apply Euroscreen’s AequoScreen™ proprietary functional assay technology in their efforts to generate novel small molecule leads across a broad range of GPCR targets. Under the terms of the agreement, Euroscreen will receive upfront and R&D payments with the potential for additional payments for successful programs. Euroscreen retains the right to aspects of the program that are not pursued by Cephalon in this collaboration. - 2004-12-22

Biometric Firm Takes Off With Safer Air Travel In airports on both sides of the Atlantic, BioWise is taking off as a leader in the provision of multi-biometric and multi-modal identification and authentication middleware for safer air travel. - 2004-11-25

How About Quality Online Radios - Check Out the Selected Top 40 Hits Online Radio More & More online radios appear each day on Live365, Yahoo! Launch, iTunes, MSN radio.... Yet, there are no real efforts on providing a quality standard for such online radios. Therefore, I decided to track many radios in each genre and present to you each month 1 or 2 online radios that I believe deserve to be qualified as Quality radios in that specific genre. - 2004-11-24 Friend of PRWeb - 5

New Portal Intends to Advance Shareware Industry. Whirling Dervishes Software announces the new web portal SharewareBlogs.com, in an attempt to advance the shareware industry, give shareware news more visibility in the press, and repair the damaged image of shareware. - 2004-11-19

Euroscreen Extends Its Patent Estate for CCR5 Chemokine Receptor and AIDS First European patent awarded for uses of CCR5 chemokine receptor, a crucial target for novel AIDS therapy - Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key European patent (0 883 687B1) in the area of HIV infection. The patent claims screening methods using the human CCR5 receptor to single out compounds as well as antibodies which can be used in the treatment and/or prevention of HIV infection. Such antibodies are also protected by claims section. - 2004-11-04

GALA Hosts Seminar on Challenges and Strategies for Success in the Enlarged EU With the European Union’s expansion to 25 countries, companies are facing new challenges and opportunities. The upcoming GALA seminar brings together experts who will discuss strategies for success in this changing environment. - 2004-11-01 Friend of PRWeb - 2

Euroscreen Provides Receptor Membranes For GE Healthcare GPCR Products Euroscreen is to help GE Healthcare, a combination of the former Amersham and GE Medical Systems, service researchers in the drug discovery industry through the supply of receptors to GE Healthcare for SPA GPCR assays. - 2004-10-20

US Patent Issued to ICOS for CCR5 Receptor Antibodies An Important Potential Therapy For AIDS Treatment. Euroscreen SA today announced the issuance of a key US patent to ICOS Corporation (“ICOS”) (Nasdaq: ICOS), on protecting antibodies which specifically bind to the CCR5 chemokine receptor. Euroscreen has exclusive worldwide rights to the ICOS CCR5 patent estate, which includes this new patent, under a previous license agreement with ICOS. - 2004-10-17

Euroscreen Receives Key US Patent Covering Screening Methods Using CCR5 Chemokine Receptor CCR5 Chemokine Receptor is a Crucial Target for a Novel AIDS Therapy. Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key US patent in the area of HIV infection. The patent claims screening methods using the human CCR5 receptor. - 2004-10-17

Euroscreen Announces European Patent on GnRH Receptor Patent Rights Available for Sublicenses Euroscreen SA today announced the issuance of the key European patent protecting the Gonadotropin-Releasing Hormone (GnRH) receptor and its key uses. Euroscreen has gained exclusive worldwide rights to the patent estate covering GnRH receptor under a previous agreement with Mount Sinai School of Medicine of New York University (MSSM) where the GnRH receptor technology was developed by Dr. Stuart Sealfon. - 2004-09-15

Euroscreen Receives Key US Patent For Purinergic Receptor Euroscreen SA today announced that it was awarded a US patent that covers the use of a G-protein-coupled receptor (GPCR) known as the human P2Y4 receptor. Euroscreen’s patent protects the sequence of P2Y4 receptor and the screening process using this receptor to find compounds that modulate its activity, and thus has significant pharmaceutical potential. - 2004-09-14